NIH’s neutral January 14, 202130 “non-recommendation,”31 issued in the face of strong evidence of ivermectin’s safety and efficacy for COVID-19, was the first obvious signal of the agency’s determination to suppress IVM. NIH claimed that there was “Insufficient evidence . . . to recommend either for or against the use of ivermectin for the treatment of COVID-19.” NIH shrouded its process for reaching that non-recommendation in secrecy, refusing to disclose the panel members who took part in the ivermectin deliberations, and redacting their names from the documents that various Freedom of
...more